Last reviewed · How we verify

NCT03074682

Novel Device for Rapid Fluid Administration

Completed NA Results posted Last updated 31 January 2019
What this trial tests

NA trial testing Lifeflow in Device Related Sepsis in 54 participants. Completed in 15 June 2017.

Timeline
1 February 2017
Primary endpoint
15 June 2017
15 June 2017

Quick facts

Lead sponsorYale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment54
Start date1 February 2017
Primary completion15 June 2017
Estimated completion15 June 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Yale University

Who can join

Eligibility, any sex, with Device Related Sepsis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Successful Administration of 60 mL/kg Primary · 20 minutes

Participants will be timed to determine if they are able to administer 60 mL/kg of fluid within a 20 minute timeframe. This outcome will be measured as a dichotomous 'yes' or 'no' as to whether the task was completed successfully. The initial registered primary outcome was changed from 60 cc/kg in 15 minutes to its current format before the study began.

GroupValue95% CI
Pressure Bag14
Push/Pull18
Lifeflow16
Time to Complete Fluid Administration Secondary · Up to 20 minutes

Participants will be timed to determine if they are able to administer 60 mL/kg of fluid within a 20 minute timeframe. The time in which they complete the task will be captured in minutes. The initial registered primary outcome was changed from 60 cc/kg in 15 minutes to its current format before the study began.

GroupValue95% CI
Pressure Bag718.9± 57.3
Push/Pull519.4± 26.3
Lifeflow376.5± 30.4
NASA Task Load Index (TLX) Secondary · 15 minutes

The NASA Task Load Index (TLX) is a series of measures that capture workload. Each scale employs a visual analog scale that measures each of the domains. The domains are Mental Domain, Physical Demand, Temporal Demand, Performance, Effort and Frustration Level. Each scale domain and the Composite has a range from 0 to 100 with 100 being the highest indicator of workload.

Composite
GroupValue95% CI
Pressure Bag42.5022.08 – 54.79
Push/Pull40.4222.29 – 48.13
Lifeflow30.0022.08 – 38.33
Mental
GroupValue95% CI
Pressure Bag60.0043.75 – 75.00
Push/Pull57.5031.25 – 68.78
Lifeflow37.5020.00 – 50.00
Physical
GroupValue95% CI
Pressure Bag20.005.00 – 57.50
Push/Pull22.5011.25 – 53.75
Lifeflow20.005.00 – 50.00
Temporal
GroupValue95% CI
Pressure Bag55.0030.00 – 71.25
Push/Pull62.5031.25 – 75.00
Lifeflow35.0023.75 – 51.25
Performance
GroupValue95% CI
Pressure Bag27.5020.00 – 47.50
Push/Pull22.5010.00 – 37.50
Lifeflow25.0020.00 – 30.00
Effort
GroupValue95% CI
Pressure Bag57.5030.00 – 75.00
Push/Pull50.0033.75 – 65.00
Lifeflow40.0020.00 – 56.25
Frustration
GroupValue95% CI
Pressure Bag15.005.00 – 40.00
Push/Pull17.506.25 – 30.00
Lifeflow12.505.00 – 17.50

Sponsor's own description

The aim of the study is to determine if a new device is more effective in fluid administration than devices currently used when resuscitating pediatric patients in septic shock. This study will take place in a simulation lab setting and will not include the use of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03074682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing